CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
47.49
+0.79 (1.69%)
At close: Jun 27, 2025, 4:00 PM
47.00
-0.49 (-1.03%)
After-hours: Jun 27, 2025, 7:56 PM EDT
CRISPR Therapeutics AG Employees
CRISPR Therapeutics AG had 393 employees as of December 31, 2024. The number of employees decreased by 14 or -3.44% compared to the previous year.
Employees
393
Change (1Y)
-14
Growth (1Y)
-3.44%
Revenue / Employee
$95,865
Profits / Employee
-$981,316
Market Cap
4.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CRSP News
- 2 days ago - CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline - GlobeNewsWire
- 14 days ago - Crispr Therapeutics: Betting On A One-Shot Future - Seeking Alpha
- 19 days ago - CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 25 days ago - CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript) - Seeking Alpha
- 4 weeks ago - CRISPR Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines - Seeking Alpha
- 7 weeks ago - CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade) - Seeking Alpha
- 7 weeks ago - Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course - Seeking Alpha